Research Journal of Medical Sciences
ISSN: Online 1993-6095ISSN: Print 1815-9346
Abstract
Glomerular diseases are the one of the common causes of end stage renal diseases worldwide probably due to prevalence of infectious diseases in developing countries. Present study was aimed to study clinical outcome of children with glomerular diseases at a tertiary hospital. Present study was prospective, observational study, conducted in children of 1‐12 years with glomerular diseases admitted at our hospital. In present study, out of 35 patients majority were <6 years (80 %) and mean age of presentation was 4.87. Out of 35 patients majority were males (60 %) and male: female ratio was 1.5:1. Out of 35 patients, 28.6% were improved with antibiotics,5.7% were improved with only anti hypertensive alone, 11.4% were improved with diuretics alone, 22.9% were improved with anti hypertensive and diuretics, 2.9% steroids alone, 20% were improved with diuretics and steroids, 2.9% were improved with diuretics, steroid and mycophenolate mofetil, 2.9% were improved only with fluids. Out of 35 patients, around 91.5% (N=32) were improved Prognosis and 8.5% (N=3) were referred to higher institution. Out of 16 patients, 100% (N=16) were found improved Prognosis PIGN. Out of 9 patients, 77.7% (N=7) were improved Prognosis NS and 22.3% (N=2) were referred to higher institution. Out of 10 patients, 90% (N=9) were improved Prognosis‐Hematuria and 10% (N=1) were referred to higher institution. Out of 9 patients, 77.7% (N=7) were Remitted Prognosis based on Steroid response and 22.3% (N=2) were referred to higher institution for Relapse. Both PIGN and Minimal change NS in children can be properly evaluated and treated promptly which shows better outcome in our study.
How to cite this article:
D. Sreenandini, Nandhini Balaji and K. Preethi. Study of Clinical Outcome of Children with Glomerular Diseases at a Tertiary Hospital.
DOI: https://doi.org/10.36478/10.36478/makrjms.2024.11.547.551
URL: https://www.makhillpublications.co/view-article/1815-9346/10.36478/makrjms.2024.11.547.551